\-\ Texto\\:\\ \ \(0\)\
\-\ \\+tnderness\\ to\\ palpation\\ over\\ mcburney\\&\\#39\\;s\\ point\\.\ \(0\)\
\-\ increased\\ wbc\\ count\ \(0\)\
\-\ fever\\ to\\ 102\\ f\ \(0\)\
\-\ treatment\\ is\\ surgical\\.\ \(1\)\
\-\ ultrasound\\ demonstrates\\ a\\ dilated\\,\\ blind\\-ended\\ tubular\\ structure\\ with\\ surrounding\\ fluid\\.\ \(0\)\
\-\ ct\\ confirms\\ a\\ massively\\ dilated\\ appendix\\ with\\ surrounding\\ inflammatory\\ changes\\.\ \(0\)\
\-\ acute\\ appendicitis\\ in\\ cystic\\ fibrosis\\ patient\ \(0\)\
\-\ prior\\ to\\ imaging\\,\\ the\\ most\\ important\\ diagnostic\\ consideration\\ is\\ to\\ rule\\ out\\ appendicitis\\.\\ \\ additional\\ entities\\ which\\ patients\\ with\\ cystic\\ fibrosis\\ are\\ predisposed\\ \\ to\\ include\\ intussusception\\,\\ crohn\\ disease\\,\\ fibrosing\\ colonopahty\\ and\\ bowel\\ wall\\ edema\\ secondary\\ to\\ hypoproteinemia\\.\ \(0\)\
\-\ 10\\ y\\.o\\.\\ girl\\ with\\ known\\ cystic\\ fibrosis\\ presents\\ with\\ acute\\ onset\\ of\\ right\\ lower\\ quadrant\\ pain\\,\\ fever\\,\\ and\\ leukocytosis\\.\ \(1\)\
\-\ although\\ the\\ pulmonary\\ manifestations\\ of\\ cystic\\ fibrosis\\ are\\ prominent\\,\\ significant\\ morbidity\\ secondary\\ to\\ gastrointestinal\\ disease\\ is\\ also\\ seen\\.\\ \\ concerning\\ bowel\\,\\ cf\\ patients\\ are\\ at\\ a\\ higher\\ risk\\ for\\ the\\ development\\ of\\ meconium\\ ileus\\,\\ meconium\\ ileus\\ equivelent\\,\\ intussusception\\,\\ gerd\\,\\ crohn\\ disease\\,\\ fibrosing\\ colonopahty\\ and\\ bowel\\ wall\\ edema\\ \\(from\\ hyproteinemia\\)\\.\ \(0\)\
\-\ with\\ respect\\ to\\ \\ appendicitis\\,\\ however\\,\\ the\\ incidence\\ is\\ actually\\ lower\\ in\\ patients\\ with\\ cf\\.\\ \\ this\\ is\\ important\\ to\\ remember\\ when\\ imaging\\ a\\ patient\\ with\\ cf\\ for\\ appendicitis\\ as\\ the\\ appendix\\ may\\ be\\ dilated\\ to\\ 6mm\\ without\\ obstruction\\ or\\ inflammation\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cf\\:\\ 0\\.09107743825637998\ \(0\)\
\-\ colonopahty\\:\\ 0\\.08087631581620641\ \(0\)\
\-\ appendicitis\\:\\ 0\\.07134430713411548\ \(0\)\
\-\ fibrosis\\:\\ 0\\.0698143693554173\ \(0\)\
\-\ fibrosing\\:\\ 0\\.05975168193552709\ \(0\)\
\-\ meconium\\:\\ 0\\.052110313835205035\ \(0\)\
\-\ ileus\\:\\ 0\\.04825844369245032\ \(0\)\
\-\ intussusception\\:\\ 0\\.04703338504451891\ \(0\)\
\-\ cystic\\:\\ 0\\.045222618481683644\ \(0\)\
\-\ dilated\\:\\ 0\\.042730615687040764\ \(0\)\
\-\ crohn\\:\\ 0\\.04189929524694623\ \(0\)\
\-\ \\+tnderness\\:\\ 0\\.040438157908103206\ \(0\)\
\-\ equivelent\\:\\ 0\\.040438157908103206\ \(0\)\
\-\ hyproteinemia\\:\\ 0\\.040438157908103206\ \(0\)\
\-\ appendix\\:\\ 0\\.038179431869807115\ \(0\)\
\-\ blind\\-ended\\:\\ 0\\.03725858368535116\ \(0\)\
\-\ hypoproteinemia\\:\\ 0\\.03725858368535116\ \(0\)\
\-\ bowel\\:\\ 0\\.03688009448923981\ \(0\)\
\-\ important\\:\\ 0\\.03521820808757729\ \(0\)\
\-\ massively\\:\\ 0\\.03305541519051559\ \(0\)\
\-\ patients\\:\\ 0\\.030434512835312285\ \(0\)\
\-\ mcburney\\:\\ 0\\.029875840967763544\ \(0\)\
\-\ predisposed\\:\\ 0\\.028332390341060734\ \(0\)\
\-\ 102\\:\\ 0\\.027179571862707953\ \(0\)\
\-\ entities\\:\\ 0\\.0269315570862388\ \(0\)\
\-\ fever\\:\\ 0\\.02652534519772446\ \(0\)\
\-\ remember\\:\\ 0\\.02647245865249117\ \(0\)\
\-\ surrounding\\:\\ 0\\.025772158388667574\ \(0\)\
\-\ 6mm\\:\\ 0\\.02567267247292797\ \(0\)\
\-\ respect\\:\\ 0\\.02499184676137626\ \(0\)\
\-\ leukocytosis\\:\\ 0\\.02412922184622516\ \(0\)\
\-\ actually\\:\\ 0\\.02412922184622516\ \(0\)\
\-\ morbidity\\:\\ 0\\.02387431427212052\ \(0\)\
\-\ gerd\\:\\ 0\\.02363282925613235\ \(0\)\
\-\ wall\\:\\ 0\\.022707881837052718\ \(0\)\
\-\ manifestations\\:\\ 0\\.022313186721949867\ \(0\)\
\-\ edema\\:\\ 0\\.022173609994782486\ \(0\)\
\-\ secondary\\:\\ 0\\.021917706114759704\ \(0\)\
\-\ consideration\\:\\ 0\\.021892051174917194\ \(0\)\
\-\ gastrointestinal\\:\\ 0\\.021360712571590945\ \(0\)\
\-\ confirms\\:\\ 0\\.02082042341720387\ \(0\)\
\-\ concerning\\:\\ 0\\.020572408640734712\ \(0\)\
\-\ f\\:\\ 0\\.020453255033380306\ \(0\)\
\-\ to\\:\\ 0\\.01959028020380671\ \(0\)\
\-\ acute\\:\\ 0\\.01935669109272014\ \(0\)\
\-\ higher\\:\\ 0\\.019222686287533153\ \(0\)\
\-\ disease\\:\\ 0\\.019221158824069325\ \(0\)\
\-\ \\,\\:\\ 0\\.018626839370455554\ \(0\)\
\-\ imaging\\:\\ 0\\.018367649765647732\ \(0\)\
\-\ tubular\\:\\ 0\\.018253378518417525\ \(0\)\
\-\ 39\\:\\ 0\\.018217116227100493\ \(0\)\
\-\ incidence\\:\\ 0\\.01797100286245682\ \(0\)\
\-\ structure\\:\\ 0\\.017802956379980764\ \(0\)\
\-\ lower\\:\\ 0\\.01763176210425562\ \(0\)\
\-\ point\\:\\ 0\\.01712896357331209\ \(0\)\
\-\ development\\:\\ 0\\.01707233129889787\ \(0\)\
\-\ count\\:\\ 0\\.017044275211661925\ \(0\)\
\-\ inflammation\\:\\ 0\\.016668508594836758\ \(0\)\
\-\ rule\\:\\ 0\\.01636924014589914\ \(0\)\
\-\ prominent\\:\\ 0\\.016088306085161895\ \(0\)\
\-\ are\\:\\ 0\\.0160303743926092\ \(0\)\
\-\ additional\\:\\ 0\\.015717645386009164\ \(0\)\
\-\ diagnostic\\:\\ 0\\.015532902729413108\ \(0\)\
\-\ \\#\\:\\ 0\\.015374709261196736\ \(0\)\
\-\ wbc\\:\\ 0\\.014289334176953267\ \(0\)\
\-\ risk\\:\\ 0\\.014198195630087554\ \(0\)\
\-\ obstruction\\:\\ 0\\.013822936002703833\ \(0\)\
\-\ quadrant\\:\\ 0\\.013795302449477315\ \(0\)\
\-\ girl\\:\\ 0\\.013781547848577056\ \(0\)\
\-\ \\&\\:\\ 0\\.013767834367621247\ \(0\)\
\-\ inflammatory\\:\\ 0\\.013593192404550569\ \(0\)\
\-\ although\\:\\ 0\\.013238207709066991\ \(0\)\
\-\ 10\\:\\ 0\\.01321387260709592\ \(0\)\
\-\ palpation\\:\\ 0\\.013082289359394735\ \(0\)\
\-\ out\\:\\ 0\\.0129543755819198\ \(0\)\
\-\ is\\:\\ 0\\.012896577485888204\ \(0\)\
\-\ known\\:\\ 0\\.012403904057173485\ \(0\)\
\-\ onset\\:\\ 0\\.012373491862041973\ \(0\)\
\-\ ultrasound\\:\\ 0\\.011629002683515154\ \(0\)\
\-\ pulmonary\\:\\ 0\\.011452065643211301\ \(0\)\
\-\ y\\.o\\:\\ 0\\.011313667121957341\ \(0\)\
\-\ s\\:\\ 0\\.011242053518874253\ \(0\)\
\-\ changes\\:\\ 0\\.011234165028601195\ \(0\)\
\-\ when\\:\\ 0\\.011226290080807366\ \(0\)\
\-\ fluid\\:\\ 0\\.011140546351393821\ \(0\)\
\-\ include\\:\\ 0\\.010996116917570123\ \(0\)\
\-\ however\\:\\ 0\\.010914532365124177\ \(0\)\
\-\ significant\\:\\ 0\\.010540583261716622\ \(0\)\
\-\ prior\\:\\ 0\\.010064737487166806\ \(0\)\
\-\ over\\:\\ 0\\.009980011881375976\ \(0\)\
\-\ increased\\:\\ 0\\.009589379733025944\ \(0\)\
\-\ \\;\\:\\ 0\\.009290922882810063\ \(0\)\
\-\ without\\:\\ 0\\.009229418194303488\ \(0\)\
\-\ most\\:\\ 0\\.009049702484991175\ \(0\)\
\-\ may\\:\\ 0\\.00859783655457855\ \(0\)\
\-\ demonstrates\\:\\ 0\\.008562482576390761\ \(0\)\
\-\ surgical\\:\\ 0\\.008239549404823182\ \(0\)\
\-\ presents\\:\\ 0\\.008007542639944614\ \(0\)\
\-\ treatment\\:\\ 0\\.007934022750462785\ \(0\)\
\-\ patient\\:\\ 0\\.007858641568040257\ \(0\)\
\-\ seen\\:\\ 0\\.00774599823425546\ \(0\)\
\-\ also\\:\\ 0\\.0077276128150006946\ \(0\)\
\-\ which\\:\\ 0\\.0073171770056997655\ \(0\)\
\-\ a\\:\\ 0\\.007277060583827546\ \(0\)\
\-\ for\\:\\ 0\\.0066890655838781204\ \(0\)\
\-\ be\\:\\ 0\\.0060447556116694\ \(0\)\
\-\ as\\:\\ 0\\.005929254614193247\ \(0\)\
\-\ from\\:\\ 0\\.00580933813373492\ \(0\)\
\-\ ct\\:\\ 0\\.005483044281614876\ \(0\)\
\-\ at\\:\\ 0\\.005310840150603822\ \(0\)\
\-\ pain\\:\\ 0\\.004787193429040068\ \(0\)\
\-\ or\\:\\ 0\\.004594141050292237\ \(0\)\
\-\ this\\:\\ 0\\.004408886299606115\ \(0\)\
\-\ with\\:\\ 0\\.004293731232656505\ \(0\)\
\-\ right\\:\\ 0\\.0041359252711487\ \(0\)\
\-\ in\\:\\ 0\\.0038660296343142656\ \(0\)\
\-\ \\(\\:\\ 0\\.0033135859002011952\ \(0\)\
\-\ \\)\\:\\ 0\\.003273108679418831\ \(0\)\
\-\ the\\:\\ 0\\.0031708551537528856\ \(0\)\
\-\ and\\:\\ 0\\.0024771881522782356\ \(0\)\
\-\ \\.\\:\\ 0\\.0019541029044410794\ \(0\)\
\-\ of\\:\\ 0\\.0016032633137337859\ \(0\)\
